Chart, Financials, Historical Prices, Industry, Insider, Messages, News, Options, Profile, Reports, Research, SEC Filings, more...

Report Screener | Stock Screener | Bond Screener | Fund Screener

Report Search Results As of 20-Jun-2013
New Screen 

All Reports | Brokerage Reports | Independent Reports
All Reports (Showing 1 to 10 of 39)
Release
Date
 [down]
Contributor Author Title Pages Price StarMine Author Rating More Info
EPS Accuracy * Portfolio Return **
19-Jun-13ValuEngine, Inc.N/AValuEngine Industry Report for Large CAP Pharma17$195.50  View Abstract
19-Jun-13Stock Traders DailyThomas H Kee Jr.Trading Report for (ABT). A detailed report, including free correlated market analysis, and updates.5$57.50  View Abstract
18-Jun-13DatamonitorDatamonitor PLCAbbott Laboratories82$175  View Abstract
18-Jun-13Thomson Reuters Stock ReportStockReports + Research DepartmentThomson Reuters Stock Report - ABBOTT LABORATORIES (ABT-N)12$25  View Abstract
18-Jun-13Thomson Reuters Stock ReportStockReports + Research DepartmentThomson Reuters Stock Report - ABSOLUTE SOFTWARE CORP (ABT-T)11$25  View Abstract
18-Jun-13Stock Traders DailyThomas H Kee Jr.The Investment Rate - a measure of investment demand.43$494.50  View Abstract
17-Jun-13Alpha Street ResearchHunter OrrABT - Abbott Laboratories - Upgraded to a Buy - Company Analysis and ASR Ranking Report9$24  View Abstract
17-Jun-13Pechala's ReportsLubomir PechalaABBOTT LABORATORIES (ABT) - REPORT FOR ACTIVE TRADERS1$25  View Abstract
17-Jun-13Market EdgeN/AMarket Edge Equity Research Report4$10  View Abstract
15-Jun-13S&P Capital IQ – STARS ReportsN/AAbbott Laboratories10$115  View Abstract
Next 20

Brokerage Reports (Showing 1 to 4 of 4)
Release
Date
 [down]
Contributor Author Title Pages Price StarMine Author Rating More Info
EPS Accuracy * Portfolio Return **
20-May-13First GlobalDevina MehraFirst Global re-initiates coverage on Abbott Inc. (ABT) with Outperform rating27$276  View Abstract
9-May-13PI Financial CorpMr. Pardeep S SanghaQ3 Meets Expectations10$115  View Abstract
9-May-13Cantor Fitzgerald CanadaMr. Tom Liston, Mr. Justin KewTop Pick; Raising target to C$10.00; Q3: Samsung and Apple support a big catalyst6$57.50  View Abstract
6-May-13Cantor Fitzgerald CanadaMr. Tom Liston, Mr. Justin KewQ3/F13 preview: Market looking through results to potential of Samsung partnership6$57.50  View Abstract

Independent Reports (Showing 1 to 10 of 35)
Release
Date
 [down]
Contributor Author Title Pages Price More Info
19-Jun-13ValuEngine, Inc.N/AValuEngine Industry Report for Large CAP Pharma17$195.50View Abstract
19-Jun-13Stock Traders DailyThomas H Kee Jr.Trading Report for (ABT). A detailed report, including free correlated market analysis, and updates.5$57.50View Abstract
18-Jun-13DatamonitorDatamonitor PLCAbbott Laboratories82$175View Abstract
18-Jun-13Thomson Reuters Stock ReportStockReports + Research DepartmentThomson Reuters Stock Report - ABBOTT LABORATORIES (ABT-N)12$25View Abstract
18-Jun-13Thomson Reuters Stock ReportStockReports + Research DepartmentThomson Reuters Stock Report - ABSOLUTE SOFTWARE CORP (ABT-T)11$25View Abstract
18-Jun-13Stock Traders DailyThomas H Kee Jr.The Investment Rate - a measure of investment demand.43$494.50View Abstract
17-Jun-13Alpha Street ResearchHunter OrrABT - Abbott Laboratories - Upgraded to a Buy - Company Analysis and ASR Ranking Report9$24View Abstract
17-Jun-13Pechala's ReportsLubomir PechalaABBOTT LABORATORIES (ABT) - REPORT FOR ACTIVE TRADERS1$25View Abstract
17-Jun-13Market EdgeN/AMarket Edge Equity Research Report4$10View Abstract
15-Jun-13S&P Capital IQ – STARS ReportsN/AAbbott Laboratories10$115View Abstract
Next 20

* EPS Accuracy is a measure of an analyst's ability to accurately estimate the EPS for a company.
** Portfolio Return is a measure of the performance of an analyst's recommendations relative to his peers.


Data and information is provided for informational purposes only, and is not intended for trading purposes. Neither Yahoo nor any of its data or content providers shall be liable for any errors or delays in the content, or for any actions taken in reliance thereon.